These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21678088)

  • 1. [Biphosphonate-induced femoral stress fractures : A new problem and knowledge so far - case report].
    Lenz R; Ellenrieder M; Skripitz R; Bader R; Pautke C; Mittelmeier W; Tischer T
    Orthopade; 2011 Dec; 40(12):1111-8. PubMed ID: 21678088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoral insufficiency fractures with bisphosphonate therapy. Cases study.
    Boszczyk A; Kowalski D; Zakrzewski P; Pomianowski S
    Ortop Traumatol Rehabil; 2011; 13(4):403-8. PubMed ID: 21857071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates.
    Skoglund K; Hjortdal O
    Tidsskr Nor Laegeforen; 2015 Jan; 135(2):116-7. PubMed ID: 25625987
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment.
    Einhorn TA; Bogdan Y; Tornetta P
    J Orthop Trauma; 2014 Jul; 28(7):433-8. PubMed ID: 24121986
    [No Abstract]   [Full Text] [Related]  

  • 5. A Scapular Spine Fracture Defined on the Basis of a Bisphosphonate: a Case Report and Review of the Literature.
    Ilyas G; Senyuva G
    Acta Chir Orthop Traumatol Cech; 2022; 89(4):312-314. PubMed ID: 36055673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.
    La Rocca Vieira R; Rosenberg ZS; Allison MB; Im SA; Babb J; Peck V
    AJR Am J Roentgenol; 2012 May; 198(5):1144-51. PubMed ID: 22528906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiresorptive Therapies for Osteoporosis.
    Weinerman S; Usera GL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):555-60. PubMed ID: 26412797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
    Isaacs JD; Shidiak L; Harris IA; Szomor ZL
    Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.
    Favinger JL; Hippe D; Ha AS
    Skeletal Radiol; 2016 May; 45(5):627-33. PubMed ID: 26880003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More on atypical fractures of the femoral diaphysis.
    Kwek EB; Koh JS; Howe TS
    N Engl J Med; 2008 Jul; 359(3):316-7; author reply 317-8. PubMed ID: 18635442
    [No Abstract]   [Full Text] [Related]  

  • 11. Femoral stress fractures associated with long-term bisphosphonate treatment.
    Ward WG; Carter CJ; Wilson SC; Emory CL
    Clin Orthop Relat Res; 2012 Mar; 470(3):759-65. PubMed ID: 22125247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-associated atypical subtrochanteric femur fracture.
    Wolin EA; Banks KP; Vroman PJ
    J Nucl Med Technol; 2015 Mar; 43(1):72-3. PubMed ID: 25125450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical femoral fractures in bisphosphonate therapy].
    Ballaschk A; Kalaitzis N; Röpke M; Piatek S
    Unfallchirurg; 2015 Jan; 118(1):88-91. PubMed ID: 24352201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, radiology and histology of atypical femoral fractures.
    Schilcher J
    Acta Orthop Suppl; 2013 Dec; 84(352):1-26. PubMed ID: 24303865
    [No Abstract]   [Full Text] [Related]  

  • 15. Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw.
    Kharazmi M; Hallberg P; Michaëlsson K
    Ann Rheum Dis; 2014 Aug; 73(8):1594. PubMed ID: 24788545
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate.
    Schilcher J; Aspenberg P
    Acta Orthop; 2009 Aug; 80(4):413-5. PubMed ID: 19568963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Ramchand SK; Chiang CY; Zebaze RM; Seeman E
    Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal complications of bisphosphonate use: what the radiologist should know.
    Haworth AE; Webb J
    Br J Radiol; 2012 Oct; 85(1018):1333-42. PubMed ID: 22972971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral femur fractures associated with short-term bisphosphonate use.
    Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K
    Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.
    Banffy MB; Vrahas MS; Ready JE; Abraham JA
    Clin Orthop Relat Res; 2011 Jul; 469(7):2028-34. PubMed ID: 21350886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.